| Original language | English |
|---|---|
| Pages (from-to) | 395 |
| Number of pages | 1 |
| Journal | The Lancet |
| Volume | 357 |
| Issue number | 9253 |
| DOIs | |
| Publication status | Published - 3 Feb 2001 |
Bibliographical note
Funding Information:As Halliday and colleagues report, a national surveillance study of neonatal group B streptococcal infection in the UK is now underway and will be completed in March, 2001. This study, through the PHLS and the British Paediatric Surveillance Unit (BPSU) is funded by the Meningitis Research Foundation (MRF). All paediatricians report cases meeting the case definition: babies younger than 90 days of age in whom group B streptococcus has been isolated from a normally sterile site. Consultants in communicable disease control and clinical microbiologists are encouraged to send isolates for characterisation to the Streptococcus and Diphtheria Reference Unit, Respiratory and Systemic Infection Laboratory at the PHLS Central Public Health Laboratory, and to report cases to the PHLS Communicable Disease Surveillance Centre. Characterisation of the serotypes of group B streptococcus that cause disease in infants in the UK might be valuable in the development of serotype-based conjugate vaccines.